166 related articles for article (PubMed ID: 12006291)
1. Diffusion-weighted imaging for differentiating recurrent cholesteatoma from granulation tissue after mastoidectomy: case report.
Maheshwari S; Mukherji SK
AJNR Am J Neuroradiol; 2002 May; 23(5):847-9. PubMed ID: 12006291
[TBL] [Abstract][Full Text] [Related]
2. Reliability of diffusion-weighted magnetic resonance imaging in differentiation of recurrent cholesteatoma and granulation tissue after intact canal wall mastoidectomy.
Allam HS; Abdel Razek AAK; Ashraf B; Khalek M
J Laryngol Otol; 2019 Dec; 133(12):1083-1086. PubMed ID: 31735177
[TBL] [Abstract][Full Text] [Related]
3. [Importance of diffusion weighted magnetic resonance imaging at differentiation of cholesteatoma and granulation tissue in patients with chronic suppurative otitis media].
Tuzcu G; Yardımcı AH; Turna Ö; Göner RE; Acıoğlu E
Kulak Burun Bogaz Ihtis Derg; 2015; 25(5):255-65. PubMed ID: 26476512
[TBL] [Abstract][Full Text] [Related]
4. MRI, not CT, to rule out recurrent cholesteatoma and avoid unnecessary second-look mastoidectomy.
Migirov L; Tal S; Eyal A; Kronenberg J
Isr Med Assoc J; 2009 Mar; 11(3):144-6. PubMed ID: 19544702
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging for cholesteatoma evaluation.
Schwartz KM; Lane JI; Neff BA; Bolster BD; Driscoll CL; Beatty CW
Ear Nose Throat J; 2010 Apr; 89(4):E14-9. PubMed ID: 20397131
[TBL] [Abstract][Full Text] [Related]
6. Cholesteatoma vs granulation tissue: a differential diagnosis by DWI-MRI apparent diffusion coefficient.
Cavaliere M; Di Lullo AM; Cantone E; Scala G; Elefante A; Russo C; Brunetti L; Motta G; Iengo M
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2237-2243. PubMed ID: 30088076
[TBL] [Abstract][Full Text] [Related]
7. Results of revision mastoidectomy.
Berçin S; Kutluhan A; Bozdemir K; Yalçiner G; Sari N; Karamese O
Acta Otolaryngol; 2009 Feb; 129(2):138-41. PubMed ID: 18607914
[TBL] [Abstract][Full Text] [Related]
8. Detection of postoperative relapsing/residual cholesteatomas with diffusion-weighted echo-planar magnetic resonance imaging.
Stasolla A; Magliulo G; Parrotto D; Luppi G; Marini M
Otol Neurotol; 2004 Nov; 25(6):879-84. PubMed ID: 15547415
[TBL] [Abstract][Full Text] [Related]
9. Recidivous cholesteatoma: DWI MR after canal wall up and canal wall down mastoidectomy.
Bakaj T; Zbrozkova LB; Salzman R; Tedla M; Starek I
Bratisl Lek Listy; 2016; 117(9):515-520. PubMed ID: 27677195
[TBL] [Abstract][Full Text] [Related]
10. Value of echo-planar diffusion-weighted MRI in the detection of secondary and postoperative relapsing/residual cholesteatoma.
Stasolla A; Magliulo G; Lo Mele L; Prossomariti G; Luppi G; Marini M
Radiol Med; 2004; 107(5-6):556-68. PubMed ID: 15195018
[TBL] [Abstract][Full Text] [Related]
11. Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma.
Migirov L; Wolf M; Greenberg G; Eyal A
Otol Neurotol; 2014 Jan; 35(1):121-5. PubMed ID: 24317217
[TBL] [Abstract][Full Text] [Related]
12. Non-echoplanar diffusion weighed imaging and T1-weighted imaging for cholesteatoma mastoid extension.
Baba A; Kurihara S; Fukuda T; Yamauchi H; Matsushima S; Ikeda K; Kurokawa R; Ota Y; Takahashi M; Sakurai Y; Motegi M; Komori M; Yamamoto K; Yamamoto Y; Kojima H; Ojiri H
Auris Nasus Larynx; 2021 Oct; 48(5):846-851. PubMed ID: 33461853
[TBL] [Abstract][Full Text] [Related]
13. The role of diffusion-weighted magnetic resonance imaging in assessing residual/recurrent cholesteatoma after canal wall down mastoidectomy.
Nash R; Kalan A; Lingam RK; Singh A
Clin Otolaryngol; 2016 Jun; 41(3):307-9. PubMed ID: 26909511
[No Abstract] [Full Text] [Related]
14. Intact canal wall mastoidectomy with tympanoplasty for cholesteatoma in children.
Dodson EE; Hashisaki GT; Hobgood TC; Lambert PR
Laryngoscope; 1998 Jul; 108(7):977-83. PubMed ID: 9665242
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of delayed postcontrast magnetic resonance imaging in the detection of residual cholesteatoma after canal wall-up tympanoplasty.
Ayache D; Williams MT; Lejeune D; Corré A
Laryngoscope; 2005 Apr; 115(4):607-10. PubMed ID: 15805868
[TBL] [Abstract][Full Text] [Related]
16. Detection of postoperative residual cholesteatoma with non-echo-planar diffusion-weighted magnetic resonance imaging.
De Foer B; Vercruysse JP; Bernaerts A; Deckers F; Pouillon M; Somers T; Casselman J; Offeciers E
Otol Neurotol; 2008 Jun; 29(4):513-7. PubMed ID: 18520587
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MR imaging sequence in the detection of postoperative recurrent cholesteatoma.
Dubrulle F; Souillard R; Chechin D; Vaneecloo FM; Desaulty A; Vincent C
Radiology; 2006 Feb; 238(2):604-10. PubMed ID: 16304085
[TBL] [Abstract][Full Text] [Related]
18. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance.
Bernardeschi D; Law-Ye B; Bielle F; Hochet B; Sterkers O; Dormont D; Pyatigorskaya N
Eur Radiol; 2019 Oct; 29(10):5617-5626. PubMed ID: 30888487
[TBL] [Abstract][Full Text] [Related]
19. HASTE diffusion-weighted MRI for the reliable detection of cholesteatoma.
Ilıca AT; Hıdır Y; Bulakbaşı N; Satar B; Güvenç I; Arslan HH; Imre N
Diagn Interv Radiol; 2012; 18(2):153-8. PubMed ID: 21960134
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MR imaging in postoperative follow-up: reliability for detection of recurrent cholesteatoma.
Cimsit NC; Cimsit C; Baysal B; Ruhi IC; Ozbilgen S; Aksoy EA
Eur J Radiol; 2010 Apr; 74(1):121-3. PubMed ID: 19231123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
